BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20541754)

  • 41. Assessing the marginal error in diagnosis and cure of Schistosoma mansoni in areas of low endemicity using Percoll and PCR techniques.
    Allam AF; Kader O; Zaki A; Shehab AY; Farag HF
    Trop Med Int Health; 2009 Mar; 14(3):316-21. PubMed ID: 19278527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
    Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
    Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia.
    Berhe N; Myrvang B; Gundersen SG
    Am J Trop Med Hyg; 2008 Feb; 78(2):228-34. PubMed ID: 18256420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
    Barakat R; Elmorshedy H; Fenwick A
    Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 29-year-old immigrant with chronic diarrhea.
    Bagdure S; Khasawneh FA
    Clin Infect Dis; 2012 Sep; 55(5):711; 746-7. PubMed ID: 22869806
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mansonian schistosomiasis in rectum--report of a case.
    Lim SD; Suh YL; Chi JG; Hong ST; Lee SH
    Korean J Parasitol; 1995 Dec; 33(4):383-6. PubMed ID: 8591017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intestinal bilharziasis with rectal bleeding: apropos of 3 cases].
    Bourée P; Cornet M; Romand S; Bisaro F
    Rev Med Interne; 1994; 15(7):481-3. PubMed ID: 7938960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measuring schistosomiasis case management of the health services in Ghana and Mali.
    van der Werf MJ; de Vlas SJ; Landouré A; Bosompem KM; Habbema JD
    Trop Med Int Health; 2004 Jan; 9(1):149-57. PubMed ID: 14728619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Malaise and abdominal complaints in a 24-year-old Swiss-African patient from Guinea: schistosomiasis mansoni].
    Lustenberger RW
    Praxis (Bern 1994); 2005 Mar; 94(9):349-50. PubMed ID: 15796464
    [No Abstract]   [Full Text] [Related]  

  • 51. Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?
    Bustinduy AL; Luzinda K; Mpoya S; Gothard P; Stone N; Wright S; Stothard JR
    Am J Trop Med Hyg; 2014 Oct; 91(4):798-800. PubMed ID: 25002295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatosplenic schistosomiasis.
    Lubeya M; Muloshi C; Baboo KS; Sianongo S; Kelly P
    Lancet; 2010 Nov; 376(9753):1645. PubMed ID: 21075257
    [No Abstract]   [Full Text] [Related]  

  • 53. ACTs for schistosomiasis: do they act?
    Utzinger J; Tanner M; Keiser J
    Lancet Infect Dis; 2010 Sep; 10(9):579-81. PubMed ID: 20705514
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibre-optic sigmoidoscopy compared with the Kato technique in diagnosis and evaluation of the intensity of Schistosoma mansoni infection.
    Abdel-Hafez MA; Bolbol AH
    Trans R Soc Trop Med Hyg; 1992; 86(6):641-3. PubMed ID: 1287929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fistula-in-ano: an unusual presentation of chronic schistosomiasis.
    Georghiou PR; Tilse MH; McCormack JG; Neely MG
    Aust N Z J Surg; 1995 Jul; 65(7):541-3. PubMed ID: 7611980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
    Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
    East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Schistosomiasis--a rare cause of iron deficiency anemia].
    Laudage G; Schirp J
    Leber Magen Darm; 1996 Jul; 26(4):216-8. PubMed ID: 8965604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan.
    Mohamed AA; Mahgoub HM; Magzoub M; Gasim GI; Eldein WN; Ahmed Ael A; Adam I
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1062-4. PubMed ID: 19261314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.
    Mwinzi PN; Karanja DM; Colley DG; Orago AS; Secor WE
    J Infect Dis; 2001 Aug; 184(4):488-96. PubMed ID: 11471107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.